Anticancer efficacy of nitazoxanide for targeting liver metastasis of uveal melanoma by disrupting the cancer bioenergetic profile

Uveal melanoma (UM) is the most common intraocular malignancy affecting adults. It originates from melanocytes within the ocular tract mainly in the choroid and to a lesser extent in the iris and ciliary body. The incidence of UM varies according to geographical location and ethnicity. Patient mortality is associated with the development of metastasis to the liver, and despite the limited control of the primary cancer and its major therapeutic dilemmas, metabolic needs of cancer have been revealed as a druggable strategy for the treatment of UM. The present study aimed to investigate the anticancer and antimetastatic effects of nitazoxanide (NTZ) using UM (Mel270 and Mel290) cell lines to assess cell viability, cell cycle, and cellular responses through western blot analysis together with a mouse model established by intrasplenic injection to evaluate liver metastasis and tumor incidence. NTZ uncouples the mitochondria by reducing the membrane potential and oxygen consumption rate in UM cancer cells. NTZ treatment in UM cells was demonstrated to notably inhibit cell growth, proliferation and the colony development in cell culture models. Moreover, NTZ halted the cell cycle at G0‑G1 stage, reducing cell migration of UM cancer cells. Mechanistically, acute treatment of UM cells with NTZ stimulated adenosine monophosphate‑activated serine/threonine protein kinase phosphorylation and downregulated mTOR and the acetyl‑CoA carboxylase signaling pathway. Furthermore, oral treatment of NTZ reduced the hepatic metastasis when UM cells were transplanted intrasplenically in male non‑obese diabetic‑severe combined immunodeficient‑γ mouse model. Overall, the findings of the current study reveal the notable role for mitochondrial oxidative phosphorylation in UM and highlight NTZ‑targeted mitochondrial function as a new therapeutic area to treat the liver metastasis of human UM.

Authors

Institutions

Publication Details

Journal
Molecular Medicine Reports
Published
2026-11-16
DOI
https://doi.org/10.3892/mmr.2026.14070
Primary Topic
Ocular Oncology and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Anticancer efficacy of nitazoxanide for targeting liver metastasis of uveal melanoma by disrupting the cancer bioenergetic profile

Noor Fadhil, Amer Alasadi, Husam Al‑Hraishawi
3 links
Molecular Medicine Reports
Ocular Oncology and Treatments
article

Anticancer efficacy of nitazoxanide for targeting liver metastasis of uveal melanoma by disrupting the cancer bioenergetic profile

Noor Fadhil, Amer Alasadi, Husam Al‑Hraishawi
article en

Abstract

Uveal melanoma (UM) is the most common intraocular malignancy affecting adults. It originates from melanocytes within the ocular tract mainly in the choroid and to a lesser extent in the iris and ciliary body. The incidence of UM varies according to geographical location and ethnicity. Patient mortality is associated with the development of metastasis to the liver, and despite the limited control of the primary cancer and its major therapeutic dilemmas, metabolic needs of cancer have been revealed as a druggable strategy for the treatment of UM. The present study aimed to investigate the anticancer and antimetastatic effects of nitazoxanide (NTZ) using UM (Mel270 and Mel290) cell lines to assess cell viability, cell cycle, and cellular responses through western blot analysis together with a mouse model established by intrasplenic injection to evaluate liver metastasis and tumor incidence. NTZ uncouples the mitochondria by reducing the membrane potential and oxygen consumption rate in UM cancer cells. NTZ treatment in UM cells was demonstrated to notably inhibit cell growth, proliferation and the colony development in cell culture models. Moreover, NTZ halted the cell cycle at G0‑G1 stage, reducing cell migration of UM cancer cells. Mechanistically, acute treatment of UM cells with NTZ stimulated adenosine monophosphate‑activated serine/threonine protein kinase phosphorylation and downregulated mTOR and the acetyl‑CoA carboxylase signaling pathway. Furthermore, oral treatment of NTZ reduced the hepatic metastasis when UM cells were transplanted intrasplenically in male non‑obese diabetic‑severe combined immunodeficient‑γ mouse model. Overall, the findings of the current study reveal the notable role for mitochondrial oxidative phosphorylation in UM and highlight NTZ‑targeted mitochondrial function as a new therapeutic area to treat the liver metastasis of human UM.

Molecular Medicine ReportsVol. 35(1)
Rutgers, The State University of New Jersey (US), Thi Qar University (IQ), University of Misan (IQ)
Good health and well-being
Ocular Oncology and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon